Software News and Research

RSS

Life Technologies launches new TaqMan Mutation Detection Assays

Life Technologies Corporation today announced the launch of its TaqMan Mutation Detection Assays -- highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies.

4 Apr 2011

AANS to hold its 79th Annual Scientific Meeting at Colorado Convention Center

The American Association of Neurological Surgeons will hold its 79th Annual Scientific Meeting at the Colorado Convention Center, April 9-13, 2011. The AANS is expected to host more than 6,000 attendees, with an estimated 3,000 medical professionals including neurosurgeons, neurosurgical residents, medical students, neuroscience nurses, clinical specialists, physician assistants and allied health professionals.

2 Apr 2011

Elmhurst Memorial Healthcare chooses Merge Cardio, Merge Hemo for new facility

Merge Healthcare Incorporated, a global corporation dedicated to health IT interoperability solutions, today announced that Elmhurst Memorial Healthcare, a 600-physician healthcare system based in Elmhurst, Illinois, selected Merge Cardio and Merge Hemo for their new 259-bed hospital.

2 Apr 2011

3M announces acquisition of Zargis Medical assets

3M announced today it has acquired certain assets of Zargis Medical Corp., maker of the only FDA-approved diagnostic software to classify suspected systolic and diastolic heart murmurs.

1 Apr 2011

New Mexico Software annual revenue decreases 5% to $3.48 million

New Mexico Software, Inc. announced today its financial results, reporting annual revenue in 2010 decreased approximately 5% to $3.48 million compared to $3.66 million in 2009.

1 Apr 2011

China BCT fourth quarter revenue increases 82.3% to $66.8 million

China BCT Pharmacy Group, Inc.,, a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the fourth quarter and full year ended December 31, 2010.

31 Mar 2011

McKesson releases Horizon Cardiology 12.2 cardiovascular information system

With its new 12.2 software release, McKesson's Horizon Cardiology™ is the industry's only cardiovascular information system (CVIS) system that offers a single database, including hemodynamics, and presents the entire patient history from fetal to adulthood.

31 Mar 2011

Researchers develop new virus-based nerve-tracing technique

If, as Shakespeare's Juliet declared, a rose by any other name smells as sweet - to you and to me and to anyone else who sniffs it - then one might assume that our odor-sensing nerve cells are all wired in the same way. Alas, they are not, according to a new study from scientists at The Scripps Research Institute.

31 Mar 2011

Allscripts ED 7.0 receives Complete EHR certification

Allscripts announced today that Allscripts ED™ 7.0, the company's standalone Emergency Department Information System (EDIS), is 2011/2012 compliant and was certified as a Complete EHR on March 2, 2011 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable hospital certification criteria adopted by the Secretary of Health and Human Services.

30 Mar 2011

Roche launces new GS GType HLA Primer Sets for HLA genotyping

454 Life Sciences, a Roche Company, announced today the launch and immediate availability of the new GS GType HLA Primer Sets for high- and medium-resolution genotyping of class I and class II loci of the Human Leukocyte Antigen (HLA) genes.

30 Mar 2011

Accelrys announces Modeling and Simulation Suite for optimizing R&D value chain

Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture.

30 Mar 2011

NUS, Agilent partner for lipidomics research

Agilent Technologies Inc. and the National University of Singapore today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states.

30 Mar 2011

McKesson awards GW with two grants to study mobile-phone use in diabetic patients

GW researchers have been awarded two grants from the McKesson Foundation as part of its Mobilizing for Health initiative, an initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology.

29 Mar 2011

SRI International, CDD receive NIAID grant to develop TB information repository

SRI International, an independent nonprofit research and development organization, and Collaborative Drug Discovery, provider of a web-based drug discovery software platform, announced that they have been awarded a grant to support the first year of a software development project focused on tuberculosis drug discovery efforts.

29 Mar 2011

Diopsys launches new Vision Testing System to detect optic nerve disease

Diopsys, Inc. has launched the new Diopsys NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.

29 Mar 2011

Backscatter airport scanners may not increase lifetime risk of cancer in travelers

Calculations by researchers at the University of California, San Francisco and the University of California, Berkeley estimate that the cancer risk associated with one type of airport security scanners is low based on the amount of radiation these devices emit, as long as they are operated and function correctly.

29 Mar 2011

Scientists develop new model that can predict early adverse drug reactions

All medications have side-effects from common aspirin to herbal remedies and from standard anticancer drugs to experimental immunosuppressants. However, predicting important side effects, serious adverse drug reactions, ADRs, is with current understanding almost impossible.

29 Mar 2011

Cleveland Medical Devices Inc. spins off Great Lakes NeuroTech

Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.

28 Mar 2011

Positron to move PosiRx system to commercial deployment

Positron Corporation is pleased to announce that its PosiRx system has met critical test standards and guidelines necessary to move on to the commercial deployment stage of its development.

28 Mar 2011

Alpha II, PCIS Gold enter integration contract

Alpha II, a leader in healthcare coding, compliance and reimbursement, announced today a new integration contract with PCIS Gold, a provider of single-source medical group practice software. Alpha II's ClaimStaker software will enhance coding reliability, while increasing professional and institutional claim validity for PCIS Gold's customers.

28 Mar 2011